We announced our financial results for the three first months of 2024.

Company announcement

Download financial workbook (xlsx)

Investor presentation (iPaper)

Earnings conference call (webcast)

London earnings conference call (webcast)

We announced our financial results for the six first months of 2024.

Company announcement

Download financial workbook (xlsx)

Investor presentation (iPaper)

Earnings conference call (webcast)

London earnings conference call  (webcast)

We are pleased to announce our financial results for the first nine months of 2024 at 07:30 CET on 06 November 2024.

Q4 and full-year 2024 financial results will be published in the first two month of 2025. Exact date to be determined.

Our CEO, Lars Fruergaard Jørgensen, presented at the Annual J.P. Morgan Healthcare Conference in San Francisco, USA on 09 January.

Listen to the webcast

Our Capital Markets Day took place on the 7th of March.

Novo Nordisk Executive Management and other members of senior management provided a full review of our strategy, operations and financial targets.

Download the presentations and watch the webcast

We held our Annual General Meeting on 21 March 2024 at 14:00 CET.

Watch recordings and download documents from our latest Annual General Meeting.

Stay informed

Stay informed

Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.

Please fill in the fields below to receive our news

E-mail address

Email is required Invalid email address
reCAPTCHA verification required

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Visit Capital Markets Day Stock information Press releases and company announcements R&D pipeline Upcoming events

Annual Report

Cover page of the Novo Nordisk Annual Report 2023

Annual Report 2023

Download Annual Report